1y9h: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
New page: left|200px<br /><applet load="1y9h" size="450" color="white" frame="true" align="right" spinBox="true" caption="1y9h" /> '''Methylation of cytosine at C5 in a CpG seque...
 
No edit summary
Line 1: Line 1:
[[Image:1y9h.gif|left|200px]]<br /><applet load="1y9h" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1y9h.gif|left|200px]]<br /><applet load="1y9h" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1y9h" />
caption="1y9h" />
'''Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement'''<br />
'''Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement'''<br />


==Overview==
==Overview==
It is well known that CpG dinucleotide steps in DNA, which are highly, methylated at the 5-position of cytosine (meC) in human tissues, exhibit a, disproportionate number of mutations within certain codons of the p53, gene. There is ample published evidence indicating that the reactivity of, guanine with anti-B[a]PDE (a metabolite of the environmental carcinogen, benzo[a]pyrene) at CpG mutation hot spots is enhanced by the methylation, of the cytosine residue flanking the target guanine residue on the, 5'-side. In this work we demonstrate that such a methylation can also, dramatically affect the conformational characteristics of an adduct, derived from the reaction of one of the two enantiomers of anti-B[a]PDE, with the exocyclic amino group of guanine ([BP]G adduct). A detailed NMR, study indicates that the 10R (-)-trans-anti-[BP]G adduct undergoes a, transition from a minor groove-binding alignment of the aromatic BP ring, system in the unmethylated C-[BP]G sequence context, to an intercalative, BP alignment with a concomitant displacement of the modified guanine, residue into the minor groove in the methylated meC-[BP]G sequence, context. By contrast, a minor groove-binding alignment was observed for, the stereoisomeric 10S (+)-trans-anti-[BP]G adduct in both the C-[BP]G and, meC-[BP]G sequence contexts. This remarkable conformational switch, resulting from the presence of a single methyl group at the 5-position of, the cytosine residue flanking the lesion on the 5'-side, is attributed to, the hydrophobic effect of the methyl group that can stabilize intercalated, adduct conformations in an adduct stereochemistry-dependent manner. Such, conformational differences in methylated and unmethylated CpG sequences, may be significant because of potential alterations in the cellular, processing of the [BP]G adducts by DNA transcription, replication, and, repair enzymes.
It is well known that CpG dinucleotide steps in DNA, which are highly methylated at the 5-position of cytosine (meC) in human tissues, exhibit a disproportionate number of mutations within certain codons of the p53 gene. There is ample published evidence indicating that the reactivity of guanine with anti-B[a]PDE (a metabolite of the environmental carcinogen benzo[a]pyrene) at CpG mutation hot spots is enhanced by the methylation of the cytosine residue flanking the target guanine residue on the 5'-side. In this work we demonstrate that such a methylation can also dramatically affect the conformational characteristics of an adduct derived from the reaction of one of the two enantiomers of anti-B[a]PDE with the exocyclic amino group of guanine ([BP]G adduct). A detailed NMR study indicates that the 10R (-)-trans-anti-[BP]G adduct undergoes a transition from a minor groove-binding alignment of the aromatic BP ring system in the unmethylated C-[BP]G sequence context, to an intercalative BP alignment with a concomitant displacement of the modified guanine residue into the minor groove in the methylated meC-[BP]G sequence context. By contrast, a minor groove-binding alignment was observed for the stereoisomeric 10S (+)-trans-anti-[BP]G adduct in both the C-[BP]G and meC-[BP]G sequence contexts. This remarkable conformational switch resulting from the presence of a single methyl group at the 5-position of the cytosine residue flanking the lesion on the 5'-side, is attributed to the hydrophobic effect of the methyl group that can stabilize intercalated adduct conformations in an adduct stereochemistry-dependent manner. Such conformational differences in methylated and unmethylated CpG sequences may be significant because of potential alterations in the cellular processing of the [BP]G adducts by DNA transcription, replication, and repair enzymes.


==About this Structure==
==About this Structure==
1Y9H is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with BAP as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1Y9H OCA].  
1Y9H is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/ ] with <scene name='pdbligand=BAP:'>BAP</scene> as [http://en.wikipedia.org/wiki/ligand ligand]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1Y9H OCA].  


==Reference==
==Reference==
Line 14: Line 14:
[[Category: Amin, S.]]
[[Category: Amin, S.]]
[[Category: Broyde, S.]]
[[Category: Broyde, S.]]
[[Category: Geacintov, N.E.]]
[[Category: Geacintov, N E.]]
[[Category: Hingerty, B.E.]]
[[Category: Hingerty, B E.]]
[[Category: Huang, X.]]
[[Category: Huang, X.]]
[[Category: Kolbanovskiy, A.]]
[[Category: Kolbanovskiy, A.]]
[[Category: Lin, C.]]
[[Category: Lin, C.]]
[[Category: Patel, D.J.]]
[[Category: Patel, D J.]]
[[Category: Zhang, N.]]
[[Category: Zhang, N.]]
[[Category: BAP]]
[[Category: BAP]]
Line 29: Line 29:
[[Category: p53 mutation hot spot]]
[[Category: p53 mutation hot spot]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 25 03:46:00 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 16:03:05 2008''

Revision as of 17:03, 21 February 2008

File:1y9h.gif


1y9h

Drag the structure with the mouse to rotate

Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement

OverviewOverview

It is well known that CpG dinucleotide steps in DNA, which are highly methylated at the 5-position of cytosine (meC) in human tissues, exhibit a disproportionate number of mutations within certain codons of the p53 gene. There is ample published evidence indicating that the reactivity of guanine with anti-B[a]PDE (a metabolite of the environmental carcinogen benzo[a]pyrene) at CpG mutation hot spots is enhanced by the methylation of the cytosine residue flanking the target guanine residue on the 5'-side. In this work we demonstrate that such a methylation can also dramatically affect the conformational characteristics of an adduct derived from the reaction of one of the two enantiomers of anti-B[a]PDE with the exocyclic amino group of guanine ([BP]G adduct). A detailed NMR study indicates that the 10R (-)-trans-anti-[BP]G adduct undergoes a transition from a minor groove-binding alignment of the aromatic BP ring system in the unmethylated C-[BP]G sequence context, to an intercalative BP alignment with a concomitant displacement of the modified guanine residue into the minor groove in the methylated meC-[BP]G sequence context. By contrast, a minor groove-binding alignment was observed for the stereoisomeric 10S (+)-trans-anti-[BP]G adduct in both the C-[BP]G and meC-[BP]G sequence contexts. This remarkable conformational switch resulting from the presence of a single methyl group at the 5-position of the cytosine residue flanking the lesion on the 5'-side, is attributed to the hydrophobic effect of the methyl group that can stabilize intercalated adduct conformations in an adduct stereochemistry-dependent manner. Such conformational differences in methylated and unmethylated CpG sequences may be significant because of potential alterations in the cellular processing of the [BP]G adducts by DNA transcription, replication, and repair enzymes.

About this StructureAbout this Structure

1Y9H is a Protein complex structure of sequences from [1] with as ligand. Full crystallographic information is available from OCA.

ReferenceReference

Methylation of cytosine at C5 in a CpG sequence context causes a conformational switch of a benzo[a]pyrene diol epoxide-N2-guanine adduct in DNA from a minor groove alignment to intercalation with base displacement., Zhang N, Lin C, Huang X, Kolbanovskiy A, Hingerty BE, Amin S, Broyde S, Geacintov NE, Patel DJ, J Mol Biol. 2005 Mar 4;346(4):951-65. Epub 2004 Dec 31. PMID:15701509 [[Category: benzo[a]pyrene]]

Page seeded by OCA on Thu Feb 21 16:03:05 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA